Journal
GYNECOLOGICAL ENDOCRINOLOGY
Volume 31, Issue 5, Pages 355-358Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/09513590.2014.995620
Keywords
Blastocyst; elevated progesterone; frozen; HCG administration; in vitro fertilization
Funding
- National Natural Science Foundation of China [30825038]
- Beijing Municipal Natural Science Foundation [7142166]
Ask authors/readers for more resources
This study analyzed the clinical outcomes of patients with elevated progesterone level on the HCG day in IVF/ICSI cycles, with different timing of embryo transfer. A total of 123 patients were involved in this prospective randomized clinical study. Group 1: blastocyst transfer group, 38 cases; Group 2: frozen thawed embryo transfer group (first FET cycle), 42 cases; Group 3: fresh embryo transfer group, 43 cases. The basal FSH level was comparable among three groups (6.7 +/- 3 versus 7.0 +/- 2 versus 6.9 +/- 2.4, p = 0.897). The clinical pregnancy rate was highest in group 2, lowest in group 3, with significantly difference (31.6% versus 38.1% versus 13.9%, p = 0.037). The implantation rate and live birth rate were still lowest in group 3 (21.9% versus 19.8% versus 6.7%, p = 0.016 and 18.4% versus 31% versus 11.6%, p = 0.081). In conclusion, the elevated progesterone level will affect clinical pregnancy rate in fresh embryo transfer cycles. We suggest frozen-thawed embryo transfer for these patients. However, for those patients who expressed the wish to have fresh embryo transfer, they should be suggested fresh blastocyst transfer, if they have more than five good quality embryos.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available